Compagnie Lombard Odier S Cm A Intercept Pharmaceuticals, Inc. Transaction History

Compagnie Lombard Odier S Cm A

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $77,770 - $120,680	1,000 New	1,000 $80,000
Q4 2017 Feb 13, 2018	SELL	$58.2 - $72.76 $90,151 - $112,705	-1,549 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $88,308 - $183,943	1,549	1,549 $90,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.